Article Versions Notes

Parosanu AI, Pirlog CF, Slavu CO, Stanciu IM, Cotan H-T, Vrabie RC, Popa A-M, Olaru M, Iaciu C, Bratu LI, et al. The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma. Current Oncology. 2023; 30(2):2457-2464. https://doi.org/10.3390/curroncol30020187

Parosanu, Andreea Ioana, Cristina Florina Pirlog, Cristina Orlov Slavu, Ioana Miruna Stanciu, Horia-Teodor Cotan, Radu Constantin Vrabie, Ana-Maria Popa, Mihaela Olaru, Cristian Iaciu, Lucian Ioan Bratu, and et al. 2023. "The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma" Current Oncology 30, no. 2: 2457-2464. https://doi.org/10.3390/curroncol30020187

Parosanu, A. I., Pirlog, C. F., Slavu, C. O., Stanciu, I. M., Cotan, H.-T., Vrabie, R. C., Popa, A.-M., Olaru, M., Iaciu, C., Bratu, L. I., Baicoianu, I. F., Moldoveanu, O., Baston, C., & Nițipir, C. (2023). The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma. Current Oncology, 30(2), 2457-2464. https://doi.org/10.3390/curroncol30020187